SCHEMBL7121674

SCHEMBL7121674

COc1ccc(S(=O)(=O)NC(CCc2ccccc2)(C(N)=O)C(C)(C)C)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.54
POLB P06746 2/20 0.53
MMP1 P03956 4/20 0.48
MMP2 P08253 4/20 0.48
MMP3 P08254 4/20 0.48
PDE4A P27815 3/20 0.48
PDE4B Q07343 3/20 0.48
PDE4C Q08493 3/20 0.48
PDE4D Q08499 3/20 0.48
LMNA P02545 2/20 0.48
HTT P42858 1/20 0.48
MMP9 P14780 2/20 0.47
MMP13 P45452 1/20 0.47
EGFR P00533 1/20 0.46
ERBB2 P04626 1/20 0.46
SGMS1 Q86VZ5 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
MAPT P10636 1/20 0.44
THRB P10828 1/20 0.44
PPARA Q07869 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7124462 0.90 GAA (0.45) ALDH1A1MMP2MMP9MMP13SMN1; SMN2
SCHEMBL7127820 0.87 GHSR (0.43) ALDH1A1MMP2MMP9MMP13MAPT
SCHEMBL7127023 0.86 GHSR (0.42) ALDH1A1POLBMMP2MMP9MMP13
SCHEMBL7125294 0.83 KMT2A (0.58) ALDH1A1POLBHTTMAPT
SCHEMBL7118409 0.83 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2MAPTPPARA
SCHEMBL7126170 0.77 F2 (0.46) ALDH1A1MMP1MMP2LMNAHTT
SCHEMBL8139629 0.76 ALDH1A1 (0.49) ALDH1A1POLBMMP1MMP2MMP3
SCHEMBL7116832 0.76 CA9 (0.39) POLBMMP1MMP2MMP9MMP13
SCHEMBL6962642 0.73 NPC1 (0.55) ALDH1A1POLBMMP1MMP2MMP3
SCHEMBL6961262 0.72 ALDH1A1 (0.53) ALDH1A1POLBMMP1MMP2MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583318-B2 Carrying out a four component condensation reaction between components consisting of a sulfonamide, an aldehyde or ketone, an isocyanide and a carboxylic acid, and one of such components being attached to a solid support ADVANCED SYNTECH, LLC 2003-06-24 US disclosed
US-20030013910-A1 Method for synthesis of alpha-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives ADVANCED SYNTECH LLC 2003-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030013910-A1 Method for synthesis of alpha-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives ASPH, COASY, HAAO ALDH1A1 391/4885POLB 1804/4885MMP1 2055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.